CPT 0505U: Vaginal Infection Testing, 32-Target Multiplex PCR

CPT code 0505U is a Proprietary Laboratory Analyses (PLA) code for a multiplex real–time PCR assay performed by NxGen MDx LLC to detect 32 pathogenic organisms from a vaginal swab, reported as present or absent. As a PLA code, 0505U is specific to a single manufacturer’s test and signals the growing role of proprietary molecular diagnostics in outpatient infectious disease evaluation. Nationally, such PLA codes matter because they influence lab billing, payer coverage policies, and access to advanced multiplex testing across care settings.

Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines payer coverage patterns, coding and billing considerations for proprietary assays, and clinical context for multiplex vaginal infection testing, including common sites where specimens are collected and where testing is performed.

Readers will learn: benchmarks and coverage trends for PLA molecular tests; the clinical scope of a 32-target vaginal PCR panel; typical service and site-of-service implications for outpatient specimen collection and laboratory processing; and practical coding considerations tied to using CPT code 0505U. Data not available in the input is noted where applicable.

Billing Code Overview

CPT code 0505U is a Proprietary Laboratory Analyses (PLA) code that applies exclusively to a single, specific laboratory test. Report 0505U only for Vaginal Infection Testing from NxGen MDx LLC. This assay uses real–time polymerase chain reaction (PCR) on a vaginal swab to detect 32 pathogenic organisms and reports each organism as present or absent.

Service Type: Molecular diagnostic laboratory test (real-time PCR, multiplex pathogen detection)

Typical Site of Service: Clinical laboratory or reference laboratory; specimen collected in ambulatory clinics, urgent care, or other outpatient settings

Clinical Context

A sexually active adult female presents to an outpatient gynecology clinic with symptoms of abnormal vaginal discharge, itching, odor, or pelvic discomfort. The clinician performs a pelvic exam and obtains a vaginal swab sample. The specimen is sent to the laboratory for the proprietary NxGen MDx LLC test reported with CPT code 0505U, a real-time PCR panel that detects 32 pathogenic organisms and reports each organism as present or absent. Results guide targeted antimicrobial or antifungal therapy, inform partner notification, and support infection control and treatment monitoring. Typical workflow: sample collection at the clinic or point-of-care, specimen transport to the performing lab, molecular analysis using the NxGen MDx platform, electronic reporting of a comprehensive organism presence/absence panel to the ordering provider, and documentation of results in the patient record with appropriate diagnosis coding and treatment planning.

Coding Specifications

Modifier	Description	When to Use
`00`	Original reference code (no modifier)	Use when no modifier applies; standard reporting of the test.
`26`

Taxonomy Code	Specialty	Notes
208100000X	Obstetrics & Gynecology	Common ordering specialty for vaginal infection testing.
390200000X	Infectious Disease	Specialist involvement for complex or recurrent infections.
207Q00000X	Family Medicine	Frequently orders testing in primary care for symptomatic patients.
363L00000X	Clinical Laboratory	Performing laboratory specialty for the technical component.
363A00000X	Pathology	May be involved when molecular diagnostic interpretation and reporting occur.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`N76.0`	Acute vaginitis	Common indication for vaginal infection PCR panel to identify causative organisms.
`N76.1`	Subacute and chronic vaginitis	Used when symptoms are persistent and comprehensive pathogen testing is indicated.
`A54.00`	Gonococcal infection of lower genitourinary tract, unspecified	Targeted STI pathogens may be detected by the panel; guides treatment.
`A56.00`	Other sexually transmitted chlamydial infections of lower genitourinary tract, unspecified	Chlamydia detection is clinically relevant for vaginal infection testing.
`B37.3`	Candidiasis of vulva and vulvovaginal area	Fungal causes of vaginitis included in differential diagnosis; PCR may detect organism DNA.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`0518U`	Data not available in the input.	Data not available in the input.
`87491`	Infectious agent detection by nucleic acid (e.g., amplification), direct probe technique; Chlamydia trachomatis	Common nucleic acid test that may be ordered alongside single-pathogen assays when targeted testing for specific STIs is needed.
`87591`	Infectious agent detection by nucleic acid (e.g., amplification), direct probe technique; Neisseria gonorrhoeae	Often ordered in parallel with vaginal infection panels for comprehensive STI screening.
`87210`	Smear, primary source with interpretation; Gram or Giemsa stain	May be performed at the time of pelvic exam to provide rapid preliminary information on organisms.
`87110`	Culture, bacterial; any source, except urine, aerobic, single isolate	May be ordered when culture-based identification or sensitivity testing is required following PCR panel results.
`99000`	Handling and/or conveyance of specimen to a laboratory	Administrative or logistical codes sometimes billed in association with specimen transport (use depends on payor).

OpenPayer

Summary & Overview